Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibition of mitosis refers to the process or mechanism by which cell division, specifically the mitotic (M) phase of the cell cycle, is blocked or disrupted. This is typically achieved by interfering with key molecular machinery required for chromosome segregation and cell division, most notably microtubule dynamics. The primary biological consequence is arresting cells in mitosis, preventing proliferation—a strategy particularly effective against rapidly dividing cancer cells. Newer strategies may also involve targeting regulatory kinases (CDKs), checkpoint proteins, or other components involved in progression through M phase or its regulation.
Disruption of microtubule dynamics (polymerization/depolymerization), leading to spindle apparatus defects and cell cycle arrest in metaphase.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibition of Mitosis (N/A).